Earable Neuroscience Unveils Global Availability of CES Innovation Awarded Device, AI-Powered Sleep Tech FRENZ™ Brainband

BOULDER, Colo., Jan. 14, 2024 /PRNewswire/ — Earable Neuroscience, the innovative deep tech company, has officially launched the FRENZ™ Brainband, an AI-powered sleep wearable that originated as a prototype at CES 2023. This marks a significant milestone in the realm of sleep technology and digital therapeutics for home use. The product, backed by early funding from Founders Fund and Samsung Ventures, is now globally available for delivery.

After securing the CES Innovation Award for Aging Technology, Earable Neuroscience announced the release of FRENZ Brainband, a groundbreaking device designed to enhance sleep quality. Paired with the FRENZ AI Sleep Science app, this wearable has undergone clinical validation, demonstrating an average reduction of 24 minutes in the time it takes for users to fall asleep, as reported in Nature Scientific Report. FRENZ is now ready for shipping worldwide through frenzband.com and has gained popularity in the Fitness & Activity Monitors category on Amazon.

The FRENZ Brainband represents a leap forward in sleep technology, offering precise tracking and real-time brain activity stimulation through non-invasive audio therapy. Its distinctive design includes bone-conduction speakers and advanced AI algorithms, promoting faster sleep onset and longer deep sleep periods. This year, Earable showcased the product at CES Eureka Park, earning a place among the finalists for the CTA Foundation Pitch.

Prof. Tam Vu, Founder and CEO of Earable Neuroscience and former professor at the University of Colorado and the University of Oxford, presented the Brainband passionately at CES. Vu emphasized FRENZ as a comprehensive, all-in-one sleep wearable providing real-time, direct stimulation with precise data to address sleep issues effectively. The device’s science-backed audio therapies are particularly beneficial for individuals dealing with challenges falling asleep or returning to sleep, especially those affected by stress, anxiety, and racing thoughts. Vu highlighted the Brainband’s proven efficacy in large-scale trials, boasting an 89% precision rate compared to the gold standard Polysomnography (PSG) and its substantial impact on reducing sleep onset time.

Speaking about the recognition received at CES, Vu stated, “As the CES Innovation Honoree for Aging Tech, we have garnered numerous accolades and interest from forward-thinking healthcare providers in the States this year. With mass production at Foxconn underway, we are poised to significantly scale up the sleep tech market. We are actively seeking strategic B2B partnerships and investments for market expansion in the healthcare and digital therapeutics space.”

The FRENZ Brainband is designed to cater to a diverse user base, ranging from wellness enthusiasts to the elderly with chronic sleep issues and those with mild sleep difficulties. Priced at $490 as a wellness device, it includes lifetime access to the standard Fast Sleep and Back to Sleep CBT-i library. Premium content and features are anticipated for future releases.

For those interested in ordering a FRENZ Brainband, visit www.frenzband.com.

About Earable Neuroscience Earable Neuroscience is a US-based deep tech company committed to delivering scalable and human-centric solutions. The FRENZ Brainband by Earable Neuroscience sets a new standard in AI-powered sleep technology, catering to the evolving needs of users.